These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4026535)

  • 1. Potential antitumor agents, XIV. 1,8-Disubstituted anthraquinones.
    Andreani A; Rambaldi M; Bonazzi D; Lelli G; Greci L; Bossa R; Galatulas I
    Arch Pharm (Weinheim); 1985 May; 318(5):400-5. PubMed ID: 4026535
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential antitumor agents, XIII. Indole derivatives related to lonidamine.
    Andreani A; Rambaldi M; Bonazzi D; Andreani F; Bossa R; Galatulas I
    Arch Pharm (Weinheim); 1984 Oct; 317(10):847-51. PubMed ID: 6517671
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation and evaluation of 2-substituted anthraquinones based on the anthracyclines.
    Bennett S; Sharples D; Brown JR
    J Med Chem; 1982 Apr; 25(4):369-73. PubMed ID: 7069715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on compounds related to antitumor agents. Synthesis of 8-substituted N6,N6-dimethyladenosine derivatives.
    Kato T; Arakawa E; Ogawa S; Suzumura Y; Kato T
    Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3635-43. PubMed ID: 3815592
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones.
    Krapcho AP; Getahun Z; Avery KL; Vargas KJ; Hacker MP; Spinelli S; Pezzoni G; Manzotti C
    J Med Chem; 1991 Aug; 34(8):2373-80. PubMed ID: 1875336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esters of 2-(1-hydroxyalkyl)-1,4-dihydroxy-9,10-anthraquinones with melphalan as multifunctional anticancer agents.
    Jin G; You Y; Ahn B
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1473-6. PubMed ID: 11378380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible antineoplastic agents II.
    De AU; Pal D
    J Pharm Sci; 1977 Feb; 66(2):232-5. PubMed ID: 839421
    [No Abstract]   [Full Text] [Related]  

  • 8. Diethylaminopropionamido-hydroxy-anthraquinones as potential anticancer agents: synthesis and characterization.
    Antonello C; Uriarte E; Palumbo M
    Arch Pharm (Weinheim); 1989 Sep; 322(9):541-4. PubMed ID: 2610587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor anthraquinones from an endophytic actinomycete Micromonospora lupini sp. nov.
    Igarashi Y; Trujillo ME; Martínez-Molina E; Yanase S; Miyanaga S; Obata T; Sakurai H; Saiki I; Fujita T; Furumai T
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3702-5. PubMed ID: 17475486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [STUDIES ON ANTITUMOR DRUGS. XIV. EXAMINATION ON STRUCTURE-ACTIVITY RELATIONSHIPS OF ANTIMONIAL CHELATES].
    CHOU TT; CHOU CH; MEI F; LIANG HC; LOH SH; HSU B
    Yao Xue Xue Bao; 1963 May; 10():266-78. PubMed ID: 14170913
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential antitumor agents X: Synthesis and antitumor activity of two nitrogen mustard derivatives related to ketocaine.
    Andreani A; Bonazzi D; Rambaldi M; Galatulas I; Bossa R
    J Pharm Sci; 1984 Aug; 73(8):1175-7. PubMed ID: 6548522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureas.
    Tsujihara K; Ozeki M; Morikawa T; Kawamori M; Akaike Y; Arai Y
    J Med Chem; 1982 Apr; 25(4):441-6. PubMed ID: 7069723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Formulation and antileukemic activity of quinolizidinylalkylaminic derivatives of naphthoquinone and anthraquinone].
    Boido Canu C; Boido V; Sparatore F
    Boll Chim Farm; 1989 Jun; 128(6):208-11. PubMed ID: 2619988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cytostatic activity of some sulfamido-anthraquinones.
    Teijeira M; Santana L; Uriarte E; Jorge ML; Seoane R
    Farmaco; 1996 Jun; 51(6):447-50. PubMed ID: 8766230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New potential cytotoxic and antitumor substances. II. Effect of hydroxyanthraquinones and their glucosides on Ehrlich ascites carcinoma cells in vitro.
    Fuska J; Fusková A; Vanĕk Z
    Neoplasma; 1976; 23(2):227-30. PubMed ID: 934391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterocyclic derivatives of 2-chloroethyl sulfide with antitumor activity.
    Peck RM; O'Connell AP; Creech HJ
    J Med Chem; 1966 Mar; 9(2):217-21. PubMed ID: 5911801
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on anti-tumor activity of isoquinoline derivatives. I. On the relationship between chemical constituion and antitumor (HeLa and Ehrlich) activity].
    Arai Y; Enomoto K
    Yakugaku Zasshi; 1968 Jan; 88(1):44-54. PubMed ID: 5692285
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and antitumor activity of a series of sulfone analogues of 1,4-naphthoquinone.
    Holshouser MH; Loeffler LJ; Hall IH
    J Med Chem; 1981 Jul; 24(7):853-8. PubMed ID: 7277393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor properties of tetrahydrobenz[a]anthraquinone derivatives.
    Morreal CE; Bernacki RJ; Hillman M; Atwood A; Cartonia D
    J Med Chem; 1990 Feb; 33(2):490-2. PubMed ID: 2299618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential antitumor agents, XV. Anthraquinone derivatives.
    Andreani A; Rambaldi M; Bonazzi D; Lelli G; Bossa R; Galatulas I
    Arch Pharm (Weinheim); 1985 Sep; 318(9):842-8. PubMed ID: 4084031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.